THYROSHIELD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thyroshield, and when can generic versions of Thyroshield launch?
Thyroshield is a drug marketed by Arco Pharms Llc and is included in one NDA.
The generic ingredient in THYROSHIELD is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thyroshield
A generic version of THYROSHIELD was approved as potassium iodide by MISSION PHARMACAL on March 24th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THYROSHIELD?
- What are the global sales for THYROSHIELD?
- What is Average Wholesale Price for THYROSHIELD?
Summary for THYROSHIELD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 212 |
| Patent Applications: | 3,426 |
| DailyMed Link: | THYROSHIELD at DailyMed |
US Patents and Regulatory Information for THYROSHIELD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arco Pharms Llc | THYROSHIELD | potassium iodide | SOLUTION;ORAL | 077218-001 | Jan 12, 2005 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
